North America

Trump tried to pass blame to the World Health Organization and says he never saw an aide's January memo warning about a potential coronavirus pandemic.

Fraud is always a problem when it comes to big government spending, but what about the $2 trillion coronavirus emergency relief plan?

Chimeric Antigen Receptor (CAR) T-cell therapy is a relatively new and powerful cancer treatment that greatly benefits patients, including the Medicare population.

GoodRx Research April 2020

The move, which will also reset copay cards to the same monthly $35 level, comes amid ongoing angst over the cost of the diabetes treatment.

On the first step toward escaping the pricing maze, Professor Salvare takes Pete Paystoomuch down the path of drug innovation, showing him why drug prices are initially more expensive – to cover all of the costs that go into developing a new medicine.

Eli Lilly and Bristol Myers Squibb roll out new plans to offer drugs at low cost or even for free.

The concern about the dependency of the US supply chain on nations such as China has been known about for some time.

Drugmaker Eli Lilly said it has capped the out-of-pocket cost for insulin to $35 per month to help diabetes patients across the U.S.

President Trump and his coronavirus task force hold a news conference.

President Donald Trump says that he will look at putting a hold on the U.S. contribution to the World Health Organization, claiming they "really blew it".

Brian Skorney, Robert W. Baird analyst who covers Gilead Sciences, joins 'Closing Bell' to discuss why he's skeptical about Gilead Science's Remdesivir clinical studies to see if the drug can treat COVID-19.

Trump keeps suggesting that hydroxychloroquine is a reliable treatment for COVID-19, flying in the face of medical experts like Dr. Fauci.

Operational considerations for 2020